ATR Inhibitor Synergizes PARP Inhibitor Cytotoxicity in Homologous Recombination Repair Deficiency TK6 Cell Lines

Figure 5

The combination of talazoparib and AZD6738 decreases the cell survival. Percent survivals are represented for each indicated genotype treated with talazoparib alone, AZD6738 alone, and the combination of talazoparib and AZD6738. The experiments were performed in triplicate with two independent experiments. Averages and standard deviations are displayed.